Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ⅱa,Open Label,Multicenter Clinical Trial to Investigate Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer

NCT01305967 is registered in ClinicalTrials.gov with SBPharmaceutical IND, Co., LTD as lead sponsor.

NCT NCT01305967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01305967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ⅱa,Open Label,Multicenter Clinical Trial to Investigate Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer
Lead sponsor
SBPharmaceutical IND, Co., LTD
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2003
Completion date
June 30, 2011
Enrollment
20 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer